WVE
Wave Life Sciences, Inc.
Biotechnology · Healthcare · United States
3.59
close · 2026-10-30
value
38
cheaper than peers38
quality
12
stronger fundamentals12
ranked against
Biotechnology (commercial)
value
quality
162 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 1.76× | 76 |
| cash flow yield, 2 years ago | -2.9% | 74 |
| earnings yield, 2 years ago | -15.0% | 51 |
| price to sales | 10.83× | 50 |
| earnings yield, 1 year ago | -19.5% | 45 |
| cash flow yield, 1 year ago | -21.5% | 31 |
| earnings yield, latest year | -33.7% | 31 |
| cash flow yield, 3 years ago | -18.2% | 31 |
| earnings yield, 3 years ago | -57.1% | 29 |
| cash flow yield, latest year | -26.6% | 27 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 9.6% | 62 |
| return on equity | -67.4% | 37 |
| revenue growth | -73.9% | 10 |
| operating margin | -3248.3% | 6 |
4 of 4 measures available
Facts
| market cap | $708M |
| free cash flow | -$128.8M |
| employees | 317 |
| first trade | 2015-11-11 |
| next earnings | 2026-10-27 |
| fundamentals updated | 2026-10-27 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -1.21 | -0.70 | -0.54 | -2.05 |
| free cash flow | -$188.2M | -$152.0M | -$20.5M | -$129.1M |
| net income | -$204.4M | -$97.0M | -$57.5M | -$161.8M |
| revenue | $42.7M | $108.3M | $113.3M | $3.6M |
| unusual items | $10.5M | $10.2M | $7.9M | $1.6M |